Peptide stacks · Healing and repair
KPV and BPC-157 stack: what’s in it and the evidence
Checked against our library and study pagesPublished by PepVault
The KPV and BPC-157 stack is two compounds run side by side, each from its own vial or form: KPV and BPC-157. The library records KPV at 100–300 mcg and BPC-157 at 200–500 mcg per dose as reference ranges.
This page describes what the crowd runs and what a vial holds. It recommends no stack and names no seller.
What’s in the KPV and BPC-157 stack
| Part | Reference range | Filed under | Evidence (library) |
|---|---|---|---|
| KPV | 100–300 mcg | Anti-inflammatory, Gut healing, Immune modulation | Emerging |
| BPC-157 | 200–500 mcg | Tissue repair, Gut healing, Tendon recovery | Emerging |
The library’s reference range per dose, part by part
KPV
KPV is one of the two parts of the KPV and BPC-157 stack. One of the smallest bioactive peptides: three amino acids from the tail end of α-MSH.
BPC-157
BPC-157 is one of the two parts of the KPV and BPC-157 stack. A peptide derived from a protective protein in the stomach.

Has the KPV and BPC-157 stack been studied as a combination?
None of our 436 study pages tested KPV and BPC-157 together, so the KPV and BPC-157 stack rests on studies of its parts and on community reports.
What the library says about the evidence for the KPV and BPC-157 stack
The two have never been tested together; the pairing rests on those separate mechanisms and on community experience.
The studies of the parts, one by one: 3 study pages on KPV (0 in people) and 14 study pages on BPC-157 (2 in people).
| Part | Study pages | In people | Strongest study page |
|---|---|---|---|
| KPV | 3 | 0 | KPV prevented colitis-linked cancer in mice; no effect without PepT1 (animal study, 2016) |
| BPC-157 | 14 | 2 | BPC-157: 10 of 12 women reported full interstitial cystitis relief (clinical trial, 2024) |
What people commonly report on the KPV and BPC-157 stack
Commonly reported: a calmer gut.
These are reports from people who run it, collected in the library, not results from a trial and not a promise of what any one person will notice.
Why these are combined
“Why KPV + BPC-157 is the gut pairing”, the library’s note on the pair (community report)
The logic runs in two directions: KPV calms inflammatory signaling (it eased colitis in mice), while BPC-157 supports healing of the gut lining (in rats).
“Why KPV pairs with BPC-157 for gut”, the KPV entry’s note (community report)
Two angles on the gut: KPV damps the inflammatory signal upstream, and BPC-157 supports healing of the gut lining downstream. Together they calm the damage and repair it at the same time. KPV blocked NF-κB and MAP-kinase signaling in human intestinal cells and eased colitis in mice (Dalmasso 2008). BPC-157 sped gut healing in rat models (Sikiric 2018 review).
How the parts of the KPV and BPC-157 stack are mixed and taken
The KPV and BPC-157 stack isn’t one pre-mixed vial in the library: each part has its own route and schedule, as its entry records them.
| Part | Route | How often | Our vial pages |
|---|---|---|---|
| KPV | SubQ injection, Oral | Daily | 5 mg vial |
| BPC-157 | SubQ injection, IM injection, Oral (less studied) | Once or twice daily | 5 mg vial, 10 mg vial |
Our vial pages work out the mix for each part’s own vial, size by size:
Compared with running the parts apart
The library’s notes on the KPV and BPC-157 stack don’t compare it with running either part on its own.
Safety notes
The KPV interaction note
In gut-focused stacks it is commonly combined with BPC-157; no combination-specific interaction studies exist.
These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.
Questions people ask
What is in the KPV and BPC-157 stack?
The KPV and BPC-157 stack is two compounds run side by side, each from its own vial or form: KPV and BPC-157. The library records KPV at 100–300 mcg and BPC-157 at 200–500 mcg per dose as reference ranges.
Has the KPV and BPC-157 stack been studied together?
Not as a combination in any of our study pages: the KPV and BPC-157 stack rests on studies of its parts and on community reports. From the library: The two have never been tested together; the pairing rests on those separate mechanisms and on community experience.
What do people report on the KPV and BPC-157 stack?
Commonly reported: a calmer gut. These are reports from people who run it.
Do the parts of the KPV and BPC-157 stack come in one vial?
No: in the library each part of the KPV and BPC-157 stack is its own compound with its own route and schedule (KPV by SubQ injection and BPC-157 by SubQ injection).
What does each part of the KPV and BPC-157 stack do?
KPV: One of the smallest bioactive peptides: three amino acids from the tail end of α-MSH. BPC-157: A peptide derived from a protective protein in the stomach.
Is there an interaction note on the KPV and BPC-157 stack?
The KPV entry: In gut-focused stacks it is commonly combined with BPC-157; no combination-specific interaction studies exist.